Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-Risk Localised Prostate Cancer (LuTectomy): A Single-Centre, Single-Arm, Phase 1/2 Study [14]. This evidence concerns the gene FOLH1 and Familial prostate cancer.